SARS

Array offered to government partners in effort to fight SARS

Published in Medical Letter on the CDC and FDA, July 27th, 2003

A new GeneChip array from Affymetrix, Inc., (AFFX) that aims to catalyze research into the SARS virus is now available to the research community through an innovative collaboration involving partners in the government, not-for-profit, and business sectors.

An initial offering of GeneChip brand SARS arrays will be distributed at no cost to qualifying researchers through the Pathogen Functional Genomics Resource Center (PFGRC), which is operated by The Institute for Genomic Research (TIGR) - a not-for-profit research institute - under contract with the National Institute for Allergy and Infectious Diseases (NIAID).

The SARS-CoV array program is part of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2003-07-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry